Aktieanalyser från populära analyshus

16 May 2025 10:03

Paxman Q1: Initial take – A bit lower sales and higher costs than expected, but no major cause for concern - Redeye

Paxman

16 May 2025 10:03

BTS Group: Q1 miss but FY guidance kept - ABG

1% organic growth (cons 4%) and EBITA -13% vs cons Reiterates 2025 guidance of EBITA 2024, Q1 EBITA ...

BTS Group

16 May 2025 10:03

Ascelia Pharma Q1'25: FDA submission ahead - ABG

EG7: Solid growth in Q1 and continued potential ahead - Redeye

Redeye updates on EG7 after Q1-results where sales came in above expectations while EBITDA was somew...

Thunderful Group: One step in the right direction - Redeye

Fable Media Group: Unlocking additional cash flow - Redeye

Redeye updates its estimates after reviewing Fable Media Group’s Q1 report, which was softer than ou...

Navigo Q1 2025: Solid prospects despite softer quarter - Redeye

Ferronordic: Temporary weakness - Nordea

We make limited revisions to our 2026-27 estimates, lowering adjusted EBIT by ~1%.

Ferronordic

16 May 2025 07:07

Rottneros: Saw trouble coming - still got cut - ABG

Rottneros

16 May 2025 07:06

Analyst Group kommenterar Titanias Q1-rapport

Titania (”Titania” eller ”Bolaget”) publicerade den 15 maj år 2025 Bolagets delårsrapport för det fö...

Titania

16 May 2025 07:05

Analyst Group kommenterar Umida Groups Q1-rapport

Umida

16 May 2025 07:04

CoinShares: Solid operating performance - ABG

Crypto prices have rebounded Solid quarter, adj. EBIT beat vs.

CoinShares

15 May 2025 15:19

Analyst Group kommenterar First Ventures Q1-rapport

First Venture

15 May 2025 14:46

Obducat: Utsikterna stärks inför helåret 2025 - Analyst Group

Obducat AB (publ) (”Obducat” eller ”Bolaget”) är en ledande leverantör av litografilösningar och har...

Första intrycket Angler Gaming, kv1 2025: Stark lönsamhet trots lägre intäkter - Carlsquare

OncoZenge Q1: Pieces falling into place - Redeye

Redeye provides a research update following the Q1 report published by OncoZenge earlier today.

OncoZenge

15 May 2025 10:50

Analyst Group Comment on Nosa Plugs Q1 Report

Alzinova Q1: Extended financial runway - Redeye

Redeye provides a research update following the Q1 report published by Alzinova earlier today.

Oncopeptides Q1 2025: Sequential sales growth of 34% - Redeye

Oncopeptides

15 May 2025 09:10

Arctic Paper: EBIT miss driven by soft pulp performance - ABG

Miss driven by Pulp Paper market better, but still not good enough Outlook remains muted Miss drive...

Fable Media Group Q1 2025: Softer than expected - Redeye

Fable Media